Share: Facebook Twitter GooglePLus LinkedIn
Activity Provided By:

i3 Health

Current Challenges and New Opportunities in Hematopoietic Stem Cell Transplant

Access Activity

Overview / Abstract:


Hematopoietic stem cell transplant is a potentially curative therapy for patients with hematologic malignancies. There are 2 primary types of HSCT: autologous, where the cells are taken from the patient, and allogeneic, where the cells come from a matched sibling donor or an unrelated donor. Advances in HSCT include the introduction of reduced-intensity conditioning regimens that allow transplant in older patients and alternative graft sources that afford a donor for nearly all patients who require a transplant. Despite these advances, studies continue to show that the use of HSCT remains suboptimal, placing many patients at increased risk for poor survival outcomes.


Hematology/oncology physicians, oncology advanced practitioners, oncology nurses, and other health care professionals involved in the treatment of patients eligible for HSCT.


Upon completion of this activity, participants should be able to:

1. Assess the susceptibility of hematologic malignancies to the graft-versus-leukemia effects of HSCT
2. Evaluate emerging data on conditioning and consolidation/maintenance therapies that can optimize HSCT outcomes
3. Apply strategies to manage transplant-related complications so that patients may achieve their goals of cancer therapy

Note: The learning objectives listed above apply to nurse practitioners and registered nurses in addition to physicians.


Jul 25, 2020


Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME


Online, Webinar / Webcast / Video

Credits / Hours

1.25 AMA PRA Category 1 Credit(s) / 1.2 ANCC Contact Hours



Presenters / Authors / Faculty

Miguel-Angel Perales, MD (Chairperson)
Deputy Chief, Adult Bone Marrow Transplantation Service
Memorial Sloan Kettering Cancer Center

Sponsors / Supporters / Grant Providers

This activity is supported by independent educational grants from Sanofi Genzyme and Incyte.

Keywords / Search Terms

i3 Health i3 Health, HSCT, stem cell transplant, hematology, oncology, oncology CME, oncology CE, free CME, free CE, ILNA points Free CE CME

Access Activity

RXinsider,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps. RXinsider,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the Terms of Service. Site Map.